Everence Capital Management’s Trueblue TBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-22,230
Closed -$424K 798
2022
Q3
$424K Sell
22,230
-5,370
-19% -$109K 0.04% 396
2022
Q2
$494K Hold
27,600
0.04% 345
2022
Q1
$797K Hold
27,600
0.06% 255
2021
Q4
$764K Buy
27,600
+4,210
+18% +$119K 0.06% 283
2021
Q3
$633K Buy
23,390
+15,990
+216% +$428K 0.05% 306
2021
Q2
$208K Buy
+7,400
New +$197K 0.02% 688

Other funds holding TBI

Everence Capital Management's TBI Position: Q4 2022 in Review

Everence Capital Management sold out of Trueblue (TBI) in Q4 2022, closing a stake of 22,230 shares — an estimated $424K sold.

Everence Capital Management first reported a position in TBI in Q2 2021 and held it in 6 quarters. The position peaked at $797K in Q1 2022. 164 funds tracked by Wall St. Rank hold TBI as of Q4 2022.

  • Everence Capital Management reported no remaining Trueblue position as of Q4 2022 after selling out during the quarter.
  • Everence Capital Management sold 22,230 Trueblue shares in Q4 2022, an estimated $424K.
  • Everence Capital Management first reported a position in Trueblue in Q2 2021 and held it in 6 quarters.
  • Everence Capital Management's Trueblue position peaked at $797K in Q1 2022.
  • 164 funds tracked by Wall St. Rank held Trueblue as of Q4 2022.

Based on Everence Capital Management's 13F filing for Q4 2022, filed 31 Jan 2023.